Patients who combine GLP-1 medications with resistance training preserve significantly more muscle than those relying on diet and medication alone
The research showed that heart-related deaths, heart attacks, and strokes affected 6.5% of people who took Wegovy, while 8% of those who got a placebo had these issues [11]
It is the first study, to our knowledge, to investigate how stigma directed at GLP-1 users compares to stigma directed at higher-weight people, and it offers a timely examination of the stigma associated with regaining weight after discontinuing a GLP-1
Patients who have taken these drugs have a higher risk of osteoporosis and gout, as discussed during the American Academy of Orthopaedic Surgeons annual meeting, according to NBC News
This is due to an inappropriately exaggerated release of histamine from mast cCells or from an increased sensitivity to histamine
doi: 10.1096/fj.201701284R 10 ChengTTWangCPanXH